Prevalence of diabetic retinopathy in women with pregestational diabetes during pregnancy and the postpartum.
Australia
diabetic retinopathy
pregestational diabetes
pregnancy
risk factors
Journal
Clinical & experimental ophthalmology
ISSN: 1442-9071
Titre abrégé: Clin Exp Ophthalmol
Pays: Australia
ID NLM: 100896531
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
27
04
2022
received:
29
09
2021
accepted:
14
05
2022
pubmed:
24
5
2022
medline:
15
10
2022
entrez:
23
5
2022
Statut:
ppublish
Résumé
Diabetic retinopathy (DR) may be affected by pregnancy. The majority of prevalence data regarding DR in pregnancy predate the advent of contemporary guidelines for diabetes management during pregnancy. This study reports DR prevalence and associated risk factors in women with pregestational diabetes during pregnancy and the postpartum in Australia. A total of 172 pregnant women with type 1 (T1DM) or type 2 diabetes diagnosed pre-pregnancy were prospectively recruited from two obstetrics hospitals in Melbourne (November 2017-March 2020). Eye examinations were scheduled in each trimester, at 3-, 6-, and 12-months postpartum. DR severity was graded from two-field fundus photographs by an independent grader utilising the Airlie House Classification. Sight-threatening DR (STDR) was defined as the presence of diabetic macular oedema or proliferative DR. Overall, 146 (84.9%) women had at least one eye examination during pregnancy. The mean age was 33.8 years (range 19-51), median diabetes duration was 7.0 years (IQR 3.0-17.0), 71 women (48.6%) had T1DM. DR and STDR prevalence during pregnancy per 100 eyes was 24.3 (95% CI 19.7-29.6) and 9.0 (95% CI 6.1-12.9); while prevalence in the postpartum was 22.2 (95% CI 16.5-29.3) and 10.0 (95% CI 5.4-17.9), respectively. T1DM, longer diabetes duration, higher HbA1c in early pregnancy, and pre-existing nephropathy were significant risk factors. The prevalence of DR in pregnant women was similar to the non-pregnant diabetic population in Australia. One in nine participants had STDR during pregnancy and the postpartum, highlighting the need to optimise DR management guidelines in pregnancy given the significant risk of vision loss.
Sections du résumé
BACKGROUND
Diabetic retinopathy (DR) may be affected by pregnancy. The majority of prevalence data regarding DR in pregnancy predate the advent of contemporary guidelines for diabetes management during pregnancy. This study reports DR prevalence and associated risk factors in women with pregestational diabetes during pregnancy and the postpartum in Australia.
METHODS
A total of 172 pregnant women with type 1 (T1DM) or type 2 diabetes diagnosed pre-pregnancy were prospectively recruited from two obstetrics hospitals in Melbourne (November 2017-March 2020). Eye examinations were scheduled in each trimester, at 3-, 6-, and 12-months postpartum. DR severity was graded from two-field fundus photographs by an independent grader utilising the Airlie House Classification. Sight-threatening DR (STDR) was defined as the presence of diabetic macular oedema or proliferative DR.
RESULTS
Overall, 146 (84.9%) women had at least one eye examination during pregnancy. The mean age was 33.8 years (range 19-51), median diabetes duration was 7.0 years (IQR 3.0-17.0), 71 women (48.6%) had T1DM. DR and STDR prevalence during pregnancy per 100 eyes was 24.3 (95% CI 19.7-29.6) and 9.0 (95% CI 6.1-12.9); while prevalence in the postpartum was 22.2 (95% CI 16.5-29.3) and 10.0 (95% CI 5.4-17.9), respectively. T1DM, longer diabetes duration, higher HbA1c in early pregnancy, and pre-existing nephropathy were significant risk factors.
CONCLUSIONS
The prevalence of DR in pregnant women was similar to the non-pregnant diabetic population in Australia. One in nine participants had STDR during pregnancy and the postpartum, highlighting the need to optimise DR management guidelines in pregnancy given the significant risk of vision loss.
Identifiants
pubmed: 35603356
doi: 10.1111/ceo.14111
pmc: PMC9796512
doi:
Substances chimiques
Glycated Hemoglobin A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
757-767Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 The Authors. Clinical & Experimental Ophthalmology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Ophthalmologists.
Références
Lancet Diabetes Endocrinol. 2021 Mar;9(3):153-164
pubmed: 33516295
Clin Exp Ophthalmol. 2022 Sep;50(7):757-767
pubmed: 35603356
Aust N Z J Obstet Gynaecol. 2015 Oct;55(5):e1-29
pubmed: 26412014
Eye Vis (Lond). 2015 Sep 30;2:17
pubmed: 26605370
Diabetologia. 2008 Jun;51(6):1041-5
pubmed: 18392803
Semin Ophthalmol. 2004 Mar-Jun;19(1-2):13-20
pubmed: 15658007
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Br J Ophthalmol. 1980 Jun;64(6):398-403
pubmed: 7387964
Clin Exp Ophthalmol. 2016 May;44(4):321-34
pubmed: 27062093
Diabet Med. 1990 May;7(4):360
pubmed: 2140091
Diabetologia. 2010 Jun;53(6):1076-83
pubmed: 20225131
Acta Ophthalmol Scand. 2006 Aug;84(4):466-74
pubmed: 16879566
Am J Ophthalmol. 2006 Sep;142(3):405-12
pubmed: 16935584
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Ophthalmology. 1991 May;98(5 Suppl):786-806
pubmed: 2062513
J Diabetes Res. 2015;2015:310239
pubmed: 25945354
Ophthalmology. 2017 Jul;124(7):977-984
pubmed: 28318640
Diabetes Care. 2008 May;31(5):899-904
pubmed: 18223030
BMJ Open. 2017 Sep 01;7(9):e016280
pubmed: 28864696
Diabet Med. 2013 Apr;30(4):475-7
pubmed: 23252726
Diabet Med. 2010 Apr;27(4):431-5
pubmed: 20536515
Isr Med Assoc J. 2020 Mar;22(3):137-141
pubmed: 32147976
Curr Diabetes Rev. 2007 May;3(2):85-93
pubmed: 18220659
Aust N Z J Obstet Gynaecol. 2019 Apr;59(2):183-194
pubmed: 30378098
Ophthalmic Epidemiol. 2007 Jul-Aug;14(4):179-83
pubmed: 17896294
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Br J Ophthalmol. 2012 May;96(5):688-93
pubmed: 22399690
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Indian J Ophthalmol. 2018 Apr;66(4):541-546
pubmed: 29582816
Diabetes Care. 1990 Jan;13(1):34-40
pubmed: 2404715